skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Dive into timely and comprehensive Parkinson’s disease market analysis from Datamonitor Healthcare.


Simply complete the required fields and download your list of this collection of current and complete Parkinson’s disease market data and analysis.


Datamonitor Healthcare is the leading intelligence, analysis, data, and information service for the global pharmaceutical industry. Datamonitor Healthcare’s independent research and analysis provides extensive coverage of major disease areas, companies, and strategic issues, giving you the power to recognize opportunities and identify threats arising from shifting market dynamics.

Parkinsons disease coverage content

New adjunctive therapies, a rising elderly population, and US drug price inflation will drive wider market growth.
Datamonitor Healthcare estimates that Parkinson’s disease sales will grow substantially in the US, Japan, and ve major EU markets, expanding from $3.2bn in 2016 to $6.0bn in 2025.
An introduction using Parkinson’s disease.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: